Home > NRC Library > ADAMS Public Documents

License 06-20972-01 for Molecular Therapeutics,Inc, authorizing use of 50 mCi C-14,H-3,I-125,P-32 & S-35 for R&D.

Accession Number: ML20205K894

Date Released: Tuesday, October 29, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20205L006 - Forwards License 06-20972-01. (2 page(s), 3/13/1986)
• ML20205L012 - Addendum to application for license,advising that guidelines for I-125 & tritium bioassay & actions re various levels of contamination established in Reg Guides 8.20 & Div 8,Task OP 713-4,will be followed.Record of 860205 telcon encl. (2 page(s), 2/21/1986)
• ML20205L020 - Forwards application for license. (1 page(s), 1/13/1986)